男女羞羞视频在线观看,国产精品黄色免费,麻豆91在线视频,美女被羞羞免费软件下载,国产的一级片,亚洲熟色妇,天天操夜夜摸,一区二区三区在线电影
Chinadaily.com.cn
 
Go Adv Search

China's mums key to Nestle baby milk deal

Updated: 2012-04-25 11:19

(Agencies)

  Comments() Print Mail Large Medium  Small

LONDON/BEIJING - The rise of the middle-class Chinese working mothers helps explain why Nestle paid nearly $12 billion for Pfizer's baby food business and could leave rivals scrambling to catch up.

Across emerging markets, nowhere more than in China, women are increasingly keeping jobs after having children -- a big driving force behind 10 percent annual growth in the $30 billion a year baby food industry.

Foreign labels such as SMA, Promil and S-26 Gold, which Nestle will get with the Pfizer deal, have a definite edge. Nestle's products include Nan, Gerber, Lactogen and Nestogen, but are less well known in China.

Baby milk was the foundation of the world's biggest food company, established in 1866 when German pharmacist Henri Nestle introduced a substitute for mothers who could not breast-feed.

Paying more for the Pfizer unit than the $10 billion that analysts had expected, Nestle trumped a bid from Danone and Mead Johnson.

The Pfizer nutrition business has 85 percent of its sales in emerging markets, and a quarter of sales in China.

Fuelled by 16 million new births a year, annual growth rates for China's baby formula market have been as high as 20 percent over the last five years. The market is forecast to double to $16 billion by 2016.

"The key strategic attraction of the deal in our view is Pfizer's No 5 position in the Chinese infant formula market where despite being global No 1 player in infant formula, Nestle has a relatively weak presence," said analyst Robert Dickinson at brokers Citi.

The Swiss giant is already market leader in milk formula in Latin America, Africa and the Middle East. This brings it the No 1 spot in Asia with its presence outside China counted too.

Globally, Nestle's baby food market share will rise to 25 percent from 19 percent - although this is likely to fall slightly after sell-offs to ensure regulatory clearance. Mead has 16 percent, Danone 14 percent and Abbott Laboratories 12 percent.

Few options for competitors

The Nestle-Pfizer business in China would only have a combined 12 percent market share behind Mead's leading 16 percent and Danone on 14 percent, but that would still be a rise from 10th place and there may be room for expansion.

Analysts looking at China expect the number of middle class households to double to 100 million by 2015.

主站蜘蛛池模板: 门头沟区| 科技| 银川市| 淄博市| 治县。| 夏河县| 县级市| 区。| 宁海县| 湾仔区| 上杭县| 儋州市| 肃北| 秦皇岛市| 灵宝市| 锦州市| 衡山县| 镇雄县| 临洮县| 北碚区| 临海市| 清涧县| 县级市| 翼城县| 泗阳县| 麦盖提县| 将乐县| 望谟县| 马山县| 噶尔县| 保靖县| 屯昌县| 胶州市| 怀柔区| 甘孜县| 苍溪县| 金川县| 郴州市| 保山市| 满洲里市| 彭阳县| 沂水县| 通榆县| 友谊县| 福清市| 平江县| 正阳县| 巴中市| 当雄县| 新龙县| 孟津县| 南昌县| 永善县| 天长市| 通化县| 扎囊县| 会昌县| 五家渠市| 资兴市| 岚皋县| 通海县| 东兰县| 隆德县| 社会| 迭部县| 昭通市| 延庆县| 昭通市| 安福县| 北川| 江门市| 金山区| 通州区| 洛宁县| 屯昌县| 余庆县| 高雄县| 鸡西市| 布尔津县| 长白| 隆昌县| 宾川县|